Market Cap 1.42B
Revenue (ttm) 263.50M
Net Income (ttm) -390.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -148.38%
Debt to Equity Ratio 0.00
Volume 10,173,295
Avg Vol 16,951,506
Day's Range N/A - N/A
Shares Out 411.96M
Stochastic %K 11%
Beta 0.76
Analysts Strong Sell
Price Target $8.36

Company Profile

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally. The company offers Amtagvi, an individualized T cell therapy for solid tumor cancer and for the treatment of adult patients with previously treated advanced, or unresectable or metastatic melanomal; and Proleukin, an int...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 260 7120
Address:
825 Industrial Road, Suite 100, San Carlos, United States
dogbone98
dogbone98 Apr. 27 at 8:43 PM
$IOVA Hey look, charlie just joined and is spamming. Must be one of our old new friends & an easy block.
0 · Reply
YungBullHOLLA
YungBullHOLLA Apr. 27 at 8:43 PM
$IOVA Charlie Omaha is a retard who just started a new account yesterday. What a cuck
0 · Reply
Tralala40
Tralala40 Apr. 27 at 8:42 PM
$IOVA New account, 4 messages in a row, all negative equals Block. All nice and quiet again.
1 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:39 PM
$IOVA You would have been up 50% if you bought $REPL after CRL with a rejected drug. iovance with an approved drug can't keep a 7 cent gain. 7 pennies. Either a buyout is in works or back to $2.X . Given no interest in options even at 30 cents ask for $4.X calls , Fred singing fu## up again, 5th year in a row.
1 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:35 PM
$IOVA If you count post approval spike, Wayne's stellar performance: 200 million diluted shares 80% stock value gone Can't even go up 10% when a major competitor bit the dust, No run before ER. You call this idiot a 'biotech kegend'???? If Fred had any shame, he will resign and forfeit all his shares. Just disgusting.
1 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:30 PM
$IOVA Never mention again Wayne as legendary investor. It's an insult to Charlie and Warren. Wayne is just a lucky assh$$$. Two years into approved therapy, diluted 200 million shares and lost 60% value. Every board of director must be in jail for this crime.
1 · Reply
JC570
JC570 Apr. 27 at 8:23 PM
$IOVA what’s the record for red days in a row?
0 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:23 PM
$IOVA ER next week, promising the moon and the mars for two years with an FDA approved drug with a clueless interim CEO for half a decade. Major competitor gone, can't move out of 3.5 for a week. Company with rejected drug is up 10% Wayne Rothbaum...vaunted Biotech legendary investor....haaa haaa haaa.
0 · Reply
MoonTargets
MoonTargets Apr. 27 at 8:15 PM
0 · Reply
NotOfTheBody
NotOfTheBody Apr. 27 at 8:10 PM
$IOVA What's the old phrase...another day, another dollar. Apparently, a phrase the Iovance C-suite is not aware off...lol.
0 · Reply
Latest News on IOVA
What's Going On With Iovance Biotherapeutics Stock On Friday?

Mar 6, 2026, 1:06 PM EST - 7 weeks ago

What's Going On With Iovance Biotherapeutics Stock On Friday?


Iovance Biotherapeutics to Present at Upcoming Conferences

Feb 26, 2026, 8:00 AM EST - 2 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences


Iovance Biotherapeutics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:30 AM EST - 2 months ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2025


Iovance Biotherapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 6 months ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2025


Iovance Biotherapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2025


Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.

Jul 10, 2025, 4:01 PM EDT - 10 months ago

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.


Iovance Biotherapeutics Transcript: AGM 2025

Jun 10, 2025, 11:00 AM EDT - 11 months ago

Iovance Biotherapeutics Transcript: AGM 2025


Iovance Biotherapeutics Transcript: KOL event

May 31, 2025, 7:00 PM EDT - 11 months ago

Iovance Biotherapeutics Transcript: KOL event


Iovance Biotherapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2025


Iovance Biotherapeutics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2024


Iovance Biotherapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2024


Iovance Biotherapeutics Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2024


Iovance Biotherapeutics Transcript: AGM 2024

Jun 11, 2024, 11:00 AM EDT - 2 years ago

Iovance Biotherapeutics Transcript: AGM 2024


Iovance Biotherapeutics Transcript: Status Update

May 31, 2024, 7:15 PM EDT - 2 years ago

Iovance Biotherapeutics Transcript: Status Update


Iovance Biotherapeutics Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2024


Iovance Biotherapeutics Earnings Call Transcript: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2023


Iovance Biotherapeutics Transcript: FDA Announcement

Feb 16, 2024, 4:15 PM EST - 2 years ago

Iovance Biotherapeutics Transcript: FDA Announcement


Iovance Biotherapeutics Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2023


Iovance Biotherapeutics Earnings Call Transcript: Q2 2023

Aug 8, 2023, 4:30 PM EDT - 2 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2023


Iovance Biotherapeutics Transcript: Status Update

Jun 26, 2023, 5:00 PM EDT - 3 years ago

Iovance Biotherapeutics Transcript: Status Update


Iovance Biotherapeutics Earnings Call Transcript: Q1 2023

May 9, 2023, 4:30 PM EDT - 3 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2023


Iovance Biotherapeutics Earnings Call Transcript: Q4 2022

Feb 28, 2023, 4:30 PM EST - 3 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2022


Iovance Biotherapeutics Transcript: Status Update

Jan 23, 2023, 8:30 AM EST - 3 years ago

Iovance Biotherapeutics Transcript: Status Update


Iovance Biotherapeutics Transcript: Corporate Update

Nov 18, 2022, 8:00 AM EST - 3 years ago

Iovance Biotherapeutics Transcript: Corporate Update


Iovance Biotherapeutics Transcript: Study Update

Nov 10, 2022, 4:30 PM EST - 3 years ago

Iovance Biotherapeutics Transcript: Study Update


Iovance Biotherapeutics Earnings Call Transcript: Q3 2022

Nov 3, 2022, 4:30 PM EDT - 3 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2022


Iovance Biotherapeutics Earnings Call Transcript: Q2 2022

Aug 4, 2022, 4:30 PM EDT - 4 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2022


Iovance Biotherapeutics Transcript: Study Update

May 26, 2022, 5:00 PM EDT - 4 years ago

Iovance Biotherapeutics Transcript: Study Update


Iovance Biotherapeutics Earnings Call Transcript: Q1 2022

May 5, 2022, 4:30 PM EDT - 4 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2022


Iovance Biotherapeutics Transcript: Study Update

Apr 6, 2022, 8:00 AM EDT - 4 years ago

Iovance Biotherapeutics Transcript: Study Update


Iovance Biotherapeutics Earnings Call Transcript: Q4 2021

Feb 24, 2022, 4:30 PM EST - 4 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2021


Iovance Biotherapeutics Transcript: Study Update

Nov 13, 2021, 5:30 PM EST - 4 years ago

Iovance Biotherapeutics Transcript: Study Update


Iovance Biotherapeutics Earnings Call Transcript: Q3 2021

Nov 4, 2021, 4:30 PM EDT - 4 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2021


Iovance Biotherapeutics Earnings Call Transcript: Q2 2021

Aug 5, 2021, 4:30 PM EDT - 5 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2021


Iovance Biotherapeutics Transcript: Study Update

Jun 29, 2021, 4:30 PM EDT - 5 years ago

Iovance Biotherapeutics Transcript: Study Update


Iovance Biotherapeutics Transcript: Status Update

Jun 6, 2021, 12:00 PM EDT - 5 years ago

Iovance Biotherapeutics Transcript: Status Update


Iovance Biotherapeutics Earnings Call Transcript: Q1 2021

May 6, 2021, 4:30 PM EDT - 5 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2021


Iovance Biotherapeutics Earnings Call Transcript: Q4 2020

Feb 25, 2021, 4:30 PM EST - 5 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2020


Iovance Biotherapeutics Earnings Call Transcript: Q3 2020

Nov 5, 2020, 4:30 PM EST - 5 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2020


Iovance Biotherapeutics Transcript: Status Update

Oct 5, 2020, 4:30 PM EDT - 6 years ago

Iovance Biotherapeutics Transcript: Status Update


Iovance Biotherapeutics Earnings Call Transcript: Q2 2020

Aug 6, 2020, 4:30 PM EDT - 6 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2020


Iovance Biotherapeutics Transcript: AGM 2020

Jun 8, 2020, 11:00 AM EDT - 6 years ago

Iovance Biotherapeutics Transcript: AGM 2020


Iovance Biotherapeutics Earnings Call Transcript: Q1 2020

May 5, 2020, 4:30 PM EDT - 6 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2020


Iovance Biotherapeutics Earnings Call Transcript: Q4 2019

Feb 25, 2020, 4:30 PM EST - 6 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2019


Iovance Biotherapeutics Earnings Call Transcript: Q3 2019

Nov 4, 2019, 4:30 PM EST - 7 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2019


Iovance Biotherapeutics Earnings Call Transcript: Q2 2019

Aug 1, 2019, 4:30 PM EDT - 7 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2019


Iovance Biotherapeutics Transcript: Status Update

May 16, 2019, 8:00 AM EDT - 7 years ago

Iovance Biotherapeutics Transcript: Status Update


Iovance Biotherapeutics Earnings Call Transcript: Q1 2019

May 7, 2019, 4:30 PM EDT - 7 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2019


Iovance Biotherapeutics Earnings Call Transcript: Q4 2018

Feb 27, 2019, 4:30 PM EST - 7 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2018


Iovance Biotherapeutics Earnings Call Transcript: Q3 2018

Nov 6, 2018, 4:30 PM EST - 8 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2018


Iovance Biotherapeutics Earnings Call Transcript: Q2 2018

Aug 6, 2018, 4:30 PM EDT - 8 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2018


Iovance Biotherapeutics Earnings Call Transcript: Q1 2018

May 10, 2018, 4:30 PM EDT - 8 years ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2018


dogbone98
dogbone98 Apr. 27 at 8:43 PM
$IOVA Hey look, charlie just joined and is spamming. Must be one of our old new friends & an easy block.
0 · Reply
YungBullHOLLA
YungBullHOLLA Apr. 27 at 8:43 PM
$IOVA Charlie Omaha is a retard who just started a new account yesterday. What a cuck
0 · Reply
Tralala40
Tralala40 Apr. 27 at 8:42 PM
$IOVA New account, 4 messages in a row, all negative equals Block. All nice and quiet again.
1 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:39 PM
$IOVA You would have been up 50% if you bought $REPL after CRL with a rejected drug. iovance with an approved drug can't keep a 7 cent gain. 7 pennies. Either a buyout is in works or back to $2.X . Given no interest in options even at 30 cents ask for $4.X calls , Fred singing fu## up again, 5th year in a row.
1 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:35 PM
$IOVA If you count post approval spike, Wayne's stellar performance: 200 million diluted shares 80% stock value gone Can't even go up 10% when a major competitor bit the dust, No run before ER. You call this idiot a 'biotech kegend'???? If Fred had any shame, he will resign and forfeit all his shares. Just disgusting.
1 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:30 PM
$IOVA Never mention again Wayne as legendary investor. It's an insult to Charlie and Warren. Wayne is just a lucky assh$$$. Two years into approved therapy, diluted 200 million shares and lost 60% value. Every board of director must be in jail for this crime.
1 · Reply
JC570
JC570 Apr. 27 at 8:23 PM
$IOVA what’s the record for red days in a row?
0 · Reply
Charlie_Omaha
Charlie_Omaha Apr. 27 at 8:23 PM
$IOVA ER next week, promising the moon and the mars for two years with an FDA approved drug with a clueless interim CEO for half a decade. Major competitor gone, can't move out of 3.5 for a week. Company with rejected drug is up 10% Wayne Rothbaum...vaunted Biotech legendary investor....haaa haaa haaa.
0 · Reply
MoonTargets
MoonTargets Apr. 27 at 8:15 PM
0 · Reply
NotOfTheBody
NotOfTheBody Apr. 27 at 8:10 PM
$IOVA What's the old phrase...another day, another dollar. Apparently, a phrase the Iovance C-suite is not aware off...lol.
0 · Reply
johnmd
johnmd Apr. 27 at 8:05 PM
$IOVA I hold onto a small position just in case they hit the jackpot but honestly it’s been a dog for years
1 · Reply
Chi_Booth
Chi_Booth Apr. 27 at 8:05 PM
$IOVA Wow, this is a special ticker.
1 · Reply
neilc1920
neilc1920 Apr. 27 at 8:03 PM
$IOVA they’re dumping this C- from A- in ibd. Fred was a liar when he said 475 mil 2 years ago. Now he is lying about remarkable growth. Just buy puts on this pig when they report
0 · Reply
ArtKatz
ArtKatz Apr. 27 at 8:01 PM
$IOVA green all day and crashes at close...if you're not convinced of the manipulation here, you are blind.
1 · Reply
YungBullHOLLA
YungBullHOLLA Apr. 27 at 8:00 PM
$IOVA queue the Art the Fart complaining post
0 · Reply
Ixnay84
Ixnay84 Apr. 27 at 8:00 PM
$IOVA there's no other reaction to this close...
0 · Reply
Itsf82
Itsf82 Apr. 27 at 8:00 PM
$IOVA nasty junk
0 · Reply
peacetrain22
peacetrain22 Apr. 27 at 7:59 PM
$IOVA wait for it….here comes the artkatz conniption fit
0 · Reply
FelixH86
FelixH86 Apr. 27 at 7:55 PM
0 · Reply
_Zerolag
_Zerolag Apr. 27 at 7:53 PM
0 · Reply
sixmilliondollarman
sixmilliondollarman Apr. 27 at 7:48 PM
$IOVA one more thing I want to highlight for today. The delay in guidance is likely due to visibility around this BRAF patient funnel and with community ATC conversion rates. Two very significant things. Regarding the community ATCs, they only started to drive revenues in Q4. By waiting for a full quarter of results they can better see if referral patterns from community practices are converting into actual infusions at a predictable rate. The delay in guidance should allow for more aggressive guidance. Therefore I have raised my guidance to $450 - $500M, higher than the highest analyst guidance. However this represents only a 70% - 89% year over year increase. I think the analysts missed the impact of the BRAF expansion 🤷‍♂️
0 · Reply
steven1x
steven1x Apr. 27 at 6:57 PM
$IOVA coming https://edge.media-server.com/mmc/p/wmx3s4fc/
0 · Reply